Pages
(Move to ...)
Home
Our Purpose
Leadership
Other Links
▼
Thursday, December 16, 2010
Novartis Europharm Ltd. Withdraws Its Application For An Extension Of Indication For Zometa (zoledronic Acid)
Novartis Europharm Ltd. Withdraws Its Application For An Extension Of Indication For Zometa (zoledronic Acid)
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment